全球骨骼切片检查市场

预计到 2030 年全球骨骼切片检查市场规模将达到 8.63 亿美元

全球骨骼切片检查市场规模预计在2024年为6.959亿美元，预计到2030年将达到8.63亿美元，在2024-2030年的分析期内，复合年增长率为3.7%。报告分析的细分市场之一—针刺活体组织切片，预计其复合年增长率为2.9%，到分析期结束时将达到5.314亿美元。开放式切片检查细分市场在分析期间内的复合年增长率预计为4.9%。

美国市场规模估计为 1.896 亿美元，中国市场预计复合年增长率为 6.6%

美国切片检查市场规模预计在2024年达到1.896亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.718亿美元，在2024-2030年的分析期间内，复合年增长率为6.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.5%和2.8%。在欧洲，预计德国的复合年增长率为2.1%。

全球骨骼切片检查市场—主要趋势和驱动因素摘要

为什么骨骼切片检查在现代诊断医学中变得越来越重要？

骨骼切片检查正成为诊断医学的基石，尤其是在评估病因不明的骨骼病变、持续性骨痛和疑似恶性肿瘤。它在识别骨癌、转移性肿瘤、骨髓炎等感染疾病以及骨质疏鬆症和柏哲氏病病等代谢性骨病等病理方面发挥关键作用。与提供结构性资讯的影像技术相比，骨骼切片检查可以直接取样组织，从而透过组织病理学和分子生物学分析进行确诊。由于癌症发病率的上升，尤其是经常扩散至骨骼的转移性癌症（例如乳癌、前列腺癌和肺癌），对骨骼切片检查进行准确和早期诊断的需求至关重要。切片检查不仅可以确认恶性肿瘤的存在，还有助于确定肿瘤的来源、恶性程度和潜在的治疗反应。针切片检查技术（例如粗针切片和细针抽吸）的进步，使得该操作的创伤性更小，在临床实践中更容易获得。此外，CT和MRI引导切片检查等影像引导技术的出现，提高了活检的准确性，并降低了风险。随着个人化医疗的日益普及，骨骼切片检查对于获取组织进行基因组和生物标记分析也至关重要，这进一步提升了其诊断价值。随着医疗保健系统越来越重视早期疗育、标靶治疗和经济高效的诊断，骨骼切片检查正逐渐成为肿瘤科、整形外科和感染疾病管理领域的重要工具。

科技进步如何彻底改变骨骼切片检查程序？

技术创新显着提高了骨骼切片检查程序的安全性、准确性和临床效用。虽然传统的开放性手术切片检查仍用于复杂病例，但它们正迅速被微创经皮手术所取代，微创经皮手术可缩短恢復时间、降低併发症风险并提高患者舒适度。 CT、萤光透视和 MRI 等成像方式与先进的切片穿刺针结合使用，可即时可视化病灶并精确放置针头。这种组合确保了高品质的样本采集，同时最大限度地减少了对周围组织的损伤。机器人和导航辅助技术开始被纳入骨骼切片检查工作流程，提供亚毫米级的精度，并能够在脊柱和骨盆等解剖学上具有挑战性的位置切片检查。此外，人们正在探索 3D 成像和扩增实境(AR) 平台用于术前规划和即时引导。在实验室方面，数位病理学、次世代定序（NGS）和分子诊断正在改变检体的分析方式，从而能够识别基因突变、分子标靶和预测性生物标记。这些技术创新使临床医生能够制定高度个人化的治疗策略，尤其是在癌症治疗方面。电子健康记录（EHR）和诊断平台的整合确保了无缝的资料传输和多学科协作。因此，诊断程序不仅更有效率，而且资讯量更大，从而能够更深入地了解疾病的发病机制和进展。这种技术与诊断的融合使骨骼切片检查成为一种高度准确的测试，可为现代治疗决策提供关键资讯。

疾病流行病学和医疗保健实践的变化如何影响骨骼切片检查市场？

疾病模式的改变和医疗保健服务模式的演变正在推动市场格局的转变。全球癌症发生率的上升，尤其是在老龄化社会中，是推动能够评估骨骼病变的诊断程序需求成长的主要因素。同样，已开发经济体和新兴经济体中慢性骨感染疾病和代谢性疾病的增加也正在创造新的需求管道。例如，糖尿病患者往往易患足部感染疾病和骨髓炎，这些疾病需要准确的诊断和针对性的治疗。此外，门诊病人和流动医疗的兴起推动了微创骨切片检查技术的应用，该技术能够在当天以最少的资源进行临床应用。这种转变降低了医疗成本，提高了病患吞吐量，同时又不影响诊断品质。同时，人们越来越重视早期发现和筛检，尤其是对于那些因骨骼相关恶性肿瘤和全身性疾病而面临骨骼併发症高风险的患者。国家卫生组织和癌症倡导团体正在宣传早期切片检查在改善存活率和治疗效果方面的益处。新兴市场诊断基础设施、临床医生培训以及患者获得专科护理的管道的逐步改善，为骨骼切片检查市场带来了新的成长机会。此外，公立医疗机构与私人诊断实验室之间的合作正在完善转诊系统，扩大诊断覆盖范围。这些因素共同作用，使骨骼切片检查能够深度融入常规诊断护理和慢性病管理。

推动全球骨骼切片检查市场成长的关键因素有哪些？

全球骨骼切片检查市场的成长受到临床、技术、人口和经济等多种因素的协同效应驱动。其中一个最重要的驱动因素是全球癌症（尤其是晚期恶性肿瘤）相关骨转移负担的持续加重。随着对准确且经组织学确诊的诊断的需求不断增长，对高效、微创的切片检查程序的需求也日益增长。随着影像引导程序的广泛应用和技术先进的医疗设施的普及，骨骼切片检查变得比以往任何时候都更安全、更快捷、更容易获得。病理学服务的改进和分子诊断的整合也鼓励临床医生利用切片检查进行个人化治疗计划，尤其是在肿瘤学领域。这是因为老年人口更容易出现骨脆性、溶骨性病变和代谢性骨病，因此需要基于组织的诊断。人们对肌肉骨骼健康的认识不断提高以及政府对医疗保健基础设施的投资正在支持包括骨骼切片检查在内的诊断服务的扩展，尤其是在亚太地区、拉丁美洲和中东地区。价值导向医疗的兴起以及对早期疗育的日益重视，促使医疗保健提供者将骨骼切片检查作为一种经济有效的工具，以防止误诊和延迟治疗。此外，医疗设备製造商也在切片穿刺针设计、影像相容性和样本储存方面不断创新，以实现更准确、更可靠的操作。随着患者对微创、更快捷、更个人化医疗的期望不断提升，预计骨骼切片检查需求将稳步增长，使其成为现代诊断和疾病管理的重要组成部分。

部分

类型（针吸活检、开放性切片检查）、导引类型（MRI 导引、CT 导引）、最终用户（医院/诊所最终用户、门诊手术中心最终用户、其他最终用户）

受访公司范例（总合36家）

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin SpA
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自全球领域专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Bone Biopsy Market to Reach US$863.0 Million by 2030

The global market for Bone Biopsy estimated at US$695.9 Million in the year 2024, is expected to reach US$863.0 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Needle Biopsy, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$531.4 Million by the end of the analysis period. Growth in the Open Biopsy segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$189.6 Million While China is Forecast to Grow at 6.6% CAGR

The Bone Biopsy market in the U.S. is estimated at US$189.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.8 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Bone Biopsy Market - Key Trends & Drivers Summarized

Why Is Bone Biopsy Gaining Critical Importance in Modern Diagnostic Medicine?

Bone biopsy is increasingly becoming a cornerstone of diagnostic medicine, particularly in the evaluation of unexplained bone lesions, persistent bone pain, or suspected malignancies. It plays a vital role in identifying conditions such as bone cancer, metastatic tumors, infections like osteomyelitis, and metabolic bone disorders such as osteoporosis and Paget’s disease. In contrast to imaging techniques that provide structural insights, a bone biopsy allows for direct tissue sampling, offering a definitive diagnosis through histopathological and molecular analysis. With the growing prevalence of cancer, especially metastatic cancers that frequently spread to the bones (e.g., breast, prostate, and lung cancer), the need for accurate and early diagnosis via bone biopsy has become paramount. It not only helps in confirming the presence of malignancy but also in determining the origin, grade, and potential treatment responses of the tumor. Advances in needle-based biopsy methods, including core needle and fine needle aspiration, have made the procedure less invasive and more accessible across clinical settings. Furthermore, the increasing availability of image-guided techniques such as CT and MRI-guided biopsies has improved precision and reduced procedural risks. As personalized medicine becomes more prominent, bone biopsies are also essential for collecting tissue needed for genomic and biomarker analysis, further enhancing their diagnostic value. With healthcare systems increasingly focusing on early intervention, targeted therapy, and cost-effective diagnostics, bone biopsy is emerging as an essential tool across oncology, orthopedics, and infectious disease management.

How Are Technological Advancements Revolutionizing Bone Biopsy Procedures?

Technological innovations are significantly enhancing the safety, accuracy, and clinical utility of bone biopsy procedures. Traditional open surgical biopsies, while still in use for complex cases, are rapidly being replaced by minimally invasive percutaneous techniques that offer shorter recovery times, lower risk of complications, and higher patient comfort. Imaging modalities such as CT, fluoroscopy, and MRI are being used in tandem with advanced biopsy needles to allow for real-time visualization of the lesion and precise needle placement. This combination minimizes damage to surrounding tissues while ensuring high-quality sample collection. Robotics and navigation-assisted technologies are beginning to be integrated into bone biopsy workflows, offering sub-millimeter accuracy and enabling biopsies in anatomically challenging locations, such as the spine or pelvis. Additionally, 3D imaging and augmented reality platforms are being explored for pre-procedural planning and real-time guidance. On the laboratory side, digital pathology, next-generation sequencing (NGS), and molecular diagnostics are transforming how bone biopsy specimens are analyzed, allowing for the identification of genetic mutations, molecular targets, and predictive biomarkers. These innovations enable clinicians to develop highly individualized treatment strategies, especially in cancer care. The integration of electronic health records (EHRs) with diagnostic platforms ensures seamless data transfer and multidisciplinary collaboration. As a result, the procedure is not only becoming more efficient but also more informative, providing deeper insights into disease pathology and progression. This fusion of technology and diagnostics is positioning bone biopsy as a high-precision procedure that delivers critical information to guide modern therapeutic decisions.

How Are Shifts in Disease Epidemiology and Healthcare Practices Impacting the Bone Biopsy Market?

Changing disease patterns and evolving healthcare delivery models are reshaping the landscape of the bone biopsy market. The global increase in cancer incidence, especially among aging populations, is a primary factor driving the demand for diagnostic procedures capable of evaluating bone involvement. Similarly, the rise of chronic bone infections and metabolic disorders in both developed and emerging economies is creating new demand channels. Patients with diabetes, for instance, are more prone to foot infections and osteomyelitis, conditions that often require bone biopsy for accurate diagnosis and targeted treatment. In addition, the push toward outpatient and ambulatory care is facilitating the use of minimally invasive bone biopsy techniques that can be performed in same-day clinical settings with minimal resources. This transition reduces healthcare costs and improves patient throughput without compromising diagnostic quality. In parallel, there is an increasing emphasis on early detection and screening, particularly for individuals at high risk of bone-related malignancies or skeletal complications from systemic diseases. National health agencies and cancer advocacy groups are promoting awareness about the benefits of early biopsy in improving survival and treatment efficacy. In developing regions, gradual improvements in diagnostic infrastructure, clinician training, and patient access to specialty care are opening up new growth opportunities for the bone biopsy market. Additionally, collaborations between public health institutions and private diagnostic labs are leading to improved referral systems and broader diagnostic reach. All of these factors are converging to integrate bone biopsy more deeply into the fabric of routine diagnostic medicine and chronic disease management.

What Key Factors Are Driving the Growth of the Global Bone Biopsy Market?

The growth in the global bone biopsy market is driven by a synergy of clinical, technological, demographic, and economic factors. One of the most significant drivers is the rising global burden of cancer, especially bone metastases associated with advanced-stage malignancies. As the demand for precise, histologically confirmed diagnoses increases, so does the need for efficient and minimally invasive biopsy procedures. The widespread adoption of image-guided techniques and the proliferation of technologically advanced healthcare facilities are making bone biopsy safer, faster, and more accessible than ever before. Improvements in pathology services and the integration of molecular diagnostics are also encouraging clinicians to rely on bone biopsy for personalized treatment planning, particularly in oncology. The global aging population is another key driver, as older adults are more prone to bone fragility, osteolytic lesions, and metabolic bone diseases that require tissue-based diagnosis. Growing awareness of musculoskeletal health and government investments in healthcare infrastructure-especially in Asia-Pacific, Latin America, and the Middle East-are supporting the expansion of diagnostic services, including bone biopsies. The rise of value-based care and a stronger focus on early intervention have incentivized healthcare providers to adopt bone biopsy as a cost-effective tool for preventing misdiagnoses and treatment delays. Furthermore, medical device manufacturers are innovating in biopsy needle design, imaging compatibility, and sample preservation, enabling more precise and reliable procedures. As patient expectations evolve toward less invasive, faster, and more personalized care, the demand for bone biopsy is expected to grow steadily, making it a critical component of modern diagnostics and disease management.

SCOPE OF STUDY:

The report analyzes the Bone Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Needle Biopsy, Open Biopsy); Guide Type (MRI-Guided, CT-Guided); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin S.p.A.
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Bone Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Bone Disorders and Cancers Throws the Spotlight on Bone Biopsy as a Diagnostic Standard
  • Increased Emphasis on Early Detection Spurs Growth in Biopsy Procedures for Suspected Bone Lesions
  • Here's How Advanced Imaging Integration Is Enhancing Accuracy and Safety of Image-Guided Bone Biopsies
  • Growth in Oncology and Orthopedic Diagnostics Expands Clinical Use of Bone Biopsy Across Healthcare Settings
  • Expansion of Minimally Invasive Procedures Strengthens the Business Case for Needle-Based Core Biopsy Techniques
  • Improved Pathology and Biomarker Analysis Tools Drive Adoption of Bone Biopsy for Personalized Treatment Planning
  • Here's the Story: How Bone Biopsy Is Becoming Central to Diagnosing Rare Bone Tumors and Metabolic Bone Disease
  • Global Growth in Cancer Screening Programs Increases Procedure Volume in Hospital and Diagnostic Labs
  • Rising Awareness Among Clinicians About Bone Marrow vs. Bone Biopsy Indications Enhances Procedural Accuracy
  • Innovation in Biopsy Needle Design and Radiolucent Markers Supports Procedural Efficiency and Patient Comfort
  • Increased Availability of CT and MRI Imaging in Emerging Markets Fuels Adoption of Image-Guided Biopsies
  • Integration with Molecular Testing Expands Role of Bone Biopsy in Precision Oncology and Targeted Therapies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bone Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Needle Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Open Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for MRI-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for CT-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION